These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pramipexole nanocrystals for transdermal permeation: Characterization and its enhancement micro-mechanism. Li Y; Wang D; Lu S; Zeng L; Wang Y; Song W; Liu J Eur J Pharm Sci; 2018 Nov; 124():80-88. PubMed ID: 30076954 [TBL] [Abstract][Full Text] [Related]
23. Local anesthetic lidocaine delivery system: chitosan and hyaluronic acid-modified layer-by-layer lipid nanoparticles. Zhang L; Wang J; Chi H; Wang S Drug Deliv; 2016 Nov; 23(9):3529-3537. PubMed ID: 27340888 [TBL] [Abstract][Full Text] [Related]
24. Nanoemulsion gel-based topical delivery of an antifungal drug: in vitro activity and in vivo evaluation. Hussain A; Samad A; Singh SK; Ahsan MN; Haque MW; Faruk A; Ahmed FJ Drug Deliv; 2016; 23(2):642-47. PubMed ID: 25013957 [TBL] [Abstract][Full Text] [Related]
25. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies. Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401 [TBL] [Abstract][Full Text] [Related]
26. Applications and delivery mechanisms of hyaluronic acid used for topical/transdermal delivery - A review. Zhu J; Tang X; Jia Y; Ho CT; Huang Q Int J Pharm; 2020 Mar; 578():119127. PubMed ID: 32036009 [TBL] [Abstract][Full Text] [Related]
27. Synthesis, physicochemical, rheological and in-vitro characterization of double-crosslinked hyaluronic acid hydrogels containing dexamethasone and PLGA/dexamethasone nanoparticles as hybrid systems for specific medical applications. Mousavi Nejad Z; Torabinejad B; Davachi SM; Zamanian A; Saeedi Garakani S; Najafi F; Nezafati N Int J Biol Macromol; 2019 Apr; 126():193-208. PubMed ID: 30583002 [TBL] [Abstract][Full Text] [Related]
28. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies. Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833 [TBL] [Abstract][Full Text] [Related]
29. Formulation of Niosomal Gel for Enhanced Transdermal Lornoxicam Delivery: In-Vitro and In-Vivo Evaluation. El-Ridy MS; Yehia SA; Mohsen AM; El-Awdan SA; Darwish AB Curr Drug Deliv; 2018; 15(1):122-133. PubMed ID: 28240177 [TBL] [Abstract][Full Text] [Related]
30. Starch nanocrystals based hydrogel: Construction, characterizations and transdermal application. Bakrudeen HB; Sudarvizhi C; Reddy BSR Mater Sci Eng C Mater Biol Appl; 2016 Nov; 68():880-889. PubMed ID: 27524091 [TBL] [Abstract][Full Text] [Related]
31. Improved transdermal delivery of morin efficiently inhibits allergic contact dermatitis. Yu J; Wan K; Sun X Int J Pharm; 2017 Sep; 530(1-2):145-154. PubMed ID: 28739503 [TBL] [Abstract][Full Text] [Related]
32. Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel. Al-Kassas R; Wen J; Cheng AE; Kim AM; Liu SSM; Yu J Carbohydr Polym; 2016 Nov; 153():176-186. PubMed ID: 27561485 [TBL] [Abstract][Full Text] [Related]
33. Synergistically engineered nanotransethosomes for co-delivery of methotrexate and baicalin for enhanced transdermal delivery against rheumatoid arthritis: formulation, characterisation and in vivo pharmacodynamic evaluation. Adin SN; Gupta I; Aqil M; Mujeeb M; Najmi AK J Drug Target; 2024 Jul; 32(6):707-723. PubMed ID: 38652489 [No Abstract] [Full Text] [Related]
34. Drug permeation through skin is inversely correlated with carrier gel rigidity. Nguyen DV; Li F; Li H; Wong BS; Low CY; Liu XY; Kang L Mol Pharm; 2015 Feb; 12(2):444-52. PubMed ID: 25495699 [TBL] [Abstract][Full Text] [Related]
35. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation. Yue Y; Zhao D; Yin Q Biomed Pharmacother; 2018 Feb; 98():813-820. PubMed ID: 29571251 [TBL] [Abstract][Full Text] [Related]
36. Transdermal delivery of selegiline from alginate-Pluronic composite thermogels. Chen CC; Fang CL; Al-Suwayeh SA; Leu YL; Fang JY Int J Pharm; 2011 Aug; 415(1-2):119-28. PubMed ID: 21645593 [TBL] [Abstract][Full Text] [Related]
37. Transdermal Drug Delivery System of Linagliptin Sustained-release Microparticle Gels: Liu J; Guo S; Hong S; Piao J; Piao M Curr Drug Deliv; 2024; 21(11):1537-1547. PubMed ID: 38243939 [TBL] [Abstract][Full Text] [Related]
38. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam. Khurana S; Jain NK; Bedi PM Life Sci; 2013 Nov; 93(21):763-72. PubMed ID: 24113071 [TBL] [Abstract][Full Text] [Related]
39. Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy. Wang Y; Wang S; Shi P Drug Deliv; 2016 Nov; 23(9):3193-3199. PubMed ID: 27045388 [TBL] [Abstract][Full Text] [Related]
40. Carboxymethyl cellulose-based rotigotine nanocrystals-loaded hydrogel for increased transdermal delivery with alleviated skin irritation. Park JS; Seo JH; Jeong MY; Yang IG; Kim JS; Kim JH; Ho MJ; Jin SG; Choi MK; Choi YS; Kang MJ Carbohydr Polym; 2024 Aug; 338():122197. PubMed ID: 38763711 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]